This might partly explain the moderately mitigated VEGF level in MSC-introduced groups while the escalating of VEGF in CB-MNC group was largely due to the role of FoxM1, a transcriptional regulator of G1/S and G2/M transition and M phase progression in the cell cycle and a multifaced regulator in pulmonary disease. Here, FOXM1 is linked to lung disorder.